Navigation Links
Heart valves that grow with the patient
Date:10/21/2008

"From Regenerative Biology to Reconstructive Therapy" (Rebirth) at the MHH, in which Haverich is developing new methods of growing tissue in his role as coordinator. All this has convinced the jury made up of renowned experts from science and business in the preliminary selection for the Federal President's Future Prize.

The German Future Prize has been awarded annually since 1997 and is considered the most important innovation award in Germany. It is given by the Federal President to honour scientists and inventors who, based on excellent research, initiate the process of bringing credible projects and products to the market. This, in the DFG's view, is what Axel Haverich does outstandingly well: "Professor Haverich is a surgeon and scientist recognised the world over with outstanding publications and patents, who at his clinic promotes an extraordinarily technology- and innovation-friendly climate," emphasised DFG President Professor Matthias Kleiner.

Haverich stands for the combination of research and clinical practice at the highest level, continued Kleiner, and is moreover committed in many different ways to scientific self-governance, most of all in the DFG Senate, of which he was a member from 2001 to 2007, and in the Senate Commission for Clinical Research.

But the nomination for the Future Prize is not only a distinction for Haverich himself, but also an affirmation of the Leibniz Prize, emphasised the DFG President. The prize, which has been awarded since 1986, brings its winners not only worldwide renown and large prize money, but also the freedom to use this money for independent research projects of their choice with a minimum of red tape. Six Leibniz recipients later went on to receive the Nobel Prize. "These heart valves that grow with the patient are impressive evidence for the forward-looking way in which this freedom can be used," Kleiner said. With his pioneering development Haverich certainly has a good chance of succ
'/>"/>

Contact: Dr. Eva-Maria Streier
em.streier@dfg.de
49-228-885-2250
Deutsche Forschungsgemeinschaft
Source:Eurekalert

Page: 1 2 3 4

Related biology news :

1. Drug-embedded microparticles bolster heart function in animal studies
2. Repair in the developing heart
3. Embryonic heart exhibits impressive regenerative capacity
4. Study provides insight on a common heart rhythm disorder
5. LIAI launches new division to look at novel approaches to heart disease and inflammation
6. Argonne scientists peer into heart of compound that may detect chemical, biological weapons
7. Researchers study how pistachios may improve heart health
8. NIH awards Clemson bioengineer $1.5 million to improve durability of tissue heart valves
9. Dark chocolate: Half a bar per week to keep at bay the risk of heart attack
10. 2 beta blockers found to also protect heart tissue
11. Human embryonic stem cell secretions minimized tissue injury after heart attack

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/5/2009)...archers at Yale University have developed syntheti... response to HIV and HIV-infected cells, as well a...hed online in the Journal of the American Chemica...ches for these diseases. , The molecules calle...M-H) and "antibody-recruiting molecule targeting p...
(Date:11/4/2009)...in natural science) , United States Using Less...r today than it did 35 years ago, despite a 30 per...e partly attributable to alternative cooling metho...ystems. According to the latest USGS water use rep...tates goes to cooling thermoelectric power plants....
(Date:11/4/2009)...y bacteria, it turns out, hold the power to help m...d the world clean up toxic waste on test sites. ,... were invented back in World War II and have been ...h-energy compounds are often used to propel tank s... , But with increased knowledge of their envir...
Breaking Biology News(10 mins):New synthetic molecules trigger immune response to HIV and prostate cancer 2USGS science picks 2USGS science picks 3USGS science picks 4USGS science picks 5USGS science picks 6USGS science picks 7Genomic research will enable greener cleanup of military explosive test sites 2Wildfires set to increase 50 percent by 2050 9392 1Wildfires set to increase 50 percent by 2050 9392 2Microban Partners With YogaDirect com to Launch Yoga Mats With Zinc Antimicrobial Technology 13234 1Microban Partners With YogaDirect com to Launch Yoga Mats With Zinc Antimicrobial Technology 13234 2Gloomy Days Dim Cognitive Powers of the Depressed 52961 1Gloomy Days Dim Cognitive Powers of the Depressed 52961 2
..., London, UK, 9 June 2008 Elsevier, a world-lead... information products and services, is pleased to ...( http://www.sciencedirect.com/science/journal/175...opics throughout the life sciences. , The aim of ... work that is interesting and challenging, and pro...
..., This release is available in Spanish . , , ...to monitor radioactivity levels in the environment...ended by Ms Natalia Alegra at the University of ...gy for distinguishing between natural radioactivit... Most countries currently have radiological monit...
..., (PHILADELPHIA) A clinical study on patients wh...lly purified extract of Chinese red yeast rice, Xu...ttacks by 45%, revascularization (bypass surgery/a...rtality by one-third and cancer mortality by two-t...tudy, was conducted on almost 5,000 patients, rang...
Other Biology News:Elsevier launches Bioscience Hypotheses 2More sensitive radiology monitoring in the Basque Country 2More sensitive radiology monitoring in the Basque Country 3Study finds Chinese food good for your heart 2
(Date:11/6/2009)...wire/ -- EUCODIS Bioscience, a company,developing,... for the,chemical industry announced today that it...dus, the leading biopharmaceutical company in Lati...Bioscience exclusive access - for the search,of en...ection of,psychrophilic bacteria strains and other...
(Date:11/6/2009)...re/ -- Calbiotech, Inc. announced today that it ha...h (SBIR) Phase I contract by the U.S. Army Medical... agreement, Calbiotech will develop analyte specif...us. ,, Dengue virus is a mosquito-born flavi...orces deployed to tropical areas of the world. Due...
(Date:11/6/2009)... Intarcia Therapeutics, Inc. delivered two present...us delivery of exenatide) program for the treatmen...Technology Meeting in San Francisco, CA: ,, (Lo...SFTU126LOGO ) ,, Continuous Subcutaneous Deli...se, HbA1c and Reduces Weight in a 28-day Phase 1b ...
(Date:11/5/2009)... Fuel economy ratings for the new 2010 model year...y.gov web site, which Oak Ridge National Laborato... of Energy and the U.S. Environmental Protection A...l economy list are hybrid electrics, led by the To...roves that hybrids have gone mainstream," said pro...
Breaking Biology Technology:EUCODIS Bioscience to Explore Novel Enzymatic Activities in Antarctic Bacteria Library From Bio Sidus 2Calbiotech Awarded U.S. Army Phase I SBIR Research Contract to Develop Analyte Specific Reagents for the Diagnosis of Dengue Fever Virus 2Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 2Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 3Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 4Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 5November 2009 story tips from the US Department of Energy's Oak Ridge National Laboratory 2November 2009 story tips from the US Department of Energy's Oak Ridge National Laboratory 3
...- Third Quarter 2007 Financial Results and Busines...0 a.m. Eastern Time -, OAKLAND, Calif., Nov. 14 ..., a developer of mechanical circulatory,support sy...l results and,host a presentation of the results a....m. Pacific / 11:30 a.m. Eastern time on November,...
...MELBOURNE, Australia, Nov. 14 Swiss experts have,...st (TST) favouring the,use of interferon-a release...or screening patients for tuberculosis (TB) infect...h as anti-TNF-a therapy). In recommendations,publi...kly, experts,advocate the use of QFT(TM) in place ...
...NEW HAVEN, CT, and TORONTO, Nov. 13 /PRNewswire/ -...nt of RiboSwitch based therapeutic agents and,Dalt...esearch collaboration,to discover new therapeutics...roprietary insights to,design and synthesize sever...oSwitch targets. BioRelix will advance these compo...
Other Biology Technology:Swiss Experts Recommend QuantiFERON(R)-TB Gold for Tuberculosis Infection Screening Prior to Initiating anti-TNF-a Therapy 2Swiss Experts Recommend QuantiFERON(R)-TB Gold for Tuberculosis Infection Screening Prior to Initiating anti-TNF-a Therapy 3BioRelix and Dalton Medicinal Chemistry Sign Research Agreement to Capitalize on RiboSwitch Technology 2
RNase H from Roche Applied Science
T4 DNA Ligase (HC) from Invitrogen
Sheep Anti-Bovine BETA-LACTOGLOBULIN A Polyclonal Antibody, Unconjugated from AbD Serotec
Rabbit Anti-Somatostatin 28 Polyclonal Antibody, Unconjugated from Abcam
Biology Products: